'Silicone related symptoms' are common in patients with fibromyalgia: No evidence for a new disease

Journal of Rheumatology

Volumn 26, Issue 5, 1999, Pages 1172-1175

  Wolfe, Frederick ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b ARTHRITIS RESEARCH CENTER FOUNDATION   (United States)

Author keywords

Fibromyalgia symptoms; Silicone breast implants

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; FIBROMYALGIA; FOREIGN BODY REACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SILICONE PROSTHESIS;

EID: 0032927782     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Sanchez-Guerrero J, Colditz GA, Karlson EW, Hunter DJ, Speizer FE, Liang MH. Silicone breast implants and the risk of connective-tissue diseases and symptoms. New Engl J Med 1995;332:1666-70.
2. Hochberg MC, Perlmutter DL, Medsger TA Jr, et al. Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arthritis Rheum 1996;39:1125-31.
3. Schusterman MA, Kroll SS, Reece GP, et al. Incidence of autoimmune disease in patients after breast reconstruction with silicone gel implants versus autogenous tissue: a preliminary report. Ann Plast Surg 1993;31:1-6.
4. Goldman JA, Greenblatt J, Joines R, White L, Aylward B, Lamm SH. Breast implants, rheumatoid arthritis, and connective tissue diseases in a clinical practice. J Clin Epidemiol 1995;48:571-82.
5. Giltay EJ, Bernelot MH, Riley AH, Tan RG. Silicone breast prostheses and rheumatic symptoms: a retrospective follow up study. Ann Rheum Dis 1994;53:194-6.
6. Gabriel SE, O'Fallon WM, Kurland LT, Beard CM, Woods JE, Melton LJ. Risk of connective-tissue diseases and other disorders after breast implantation. New Engl J Med 1994;330:1697-702.
7. Hennekens CH, Lee I, Cook NR, et al. Self-reported breast implants and connective-tissue diseases in female health professionals: a retrospective cohort study. JAMA 1996;275:616-21.
8. Edworthy SM, Martin L, Barr SG, Birdsell DC, Brant RF, Fritzler MJ. A clinical study of the relationship between silicone breast implants and connective tissue disease. J Rheumatol 1998; 25:254-60.
9. Williams HJ, Weisman MH, Berry CC. Breast implants in patients with differentiated and undifferentiated connective tissue disease. Arthritis Rheum 1997;40:437-40.
10. Bridges AJ. Rheumatic disorders in patients with silicone implants: a critical review. J Biomater Sci Polym Ed 1995;7:147-57.
11. Borenstein D. Siliconosis: a spectrum of illness. Semin Arthritis Rheum 1994;24 Suppl 1:1-7.
12. Cuellar ML, Gluck O, Molina JF, Gutierrez S, Garcia C, Espinoza R. Silicone breast implant associated musculoskeletal manifestations. Clin Rheumatol 1995;14:667-72.
13. Kossovsky N, Gornbein JA, Zeidler M, et al. Self-reported signs and symptoms in breast implant patients with novel antibodies to silicone surface associated antigens [anti- SSAA(x)] [published erratum appears in J Appl Biomater 1995;6:305]. J Appl Biomater 1995;6:153-60.
14. Freundlich B, Altman C, Snadorfi N, Greenberg M, Tomaszewski J. A profile of symptomatic patients with silicone breast implants: a Sjogrens-like syndrome. Semin Arthritis Rheum 1994;24 Suppl 1:44-53.
15. Vasey FB, Havice DL, Bocanegra TS, et al. Clinical findings in symptomatic women with silicone breast implants. Semin Arthritis Rheum 1994;24 Suppl 1:22-8.
16. Solomon G. A clinical and laboratory profile of symptomatic women with silicone breast implants. Semin Arthritis Rheum 1994;24 Suppl 1:29-37.
17. Bridges AJ, Conley C, Wang G, Burns DE, Vasey FB. A clinical and immunologie evaluation of women with silicone breast implants and symptoms of rheumatic disease. Ann Intern Med 1993;118:929-36.
18. Wolfe F, Anderson J, Harkness D, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia [see comments]. Arthritis Rheum 1997;40:1560-70.
19. Wolfe F, Anderson J, Harkness D, et al. Work and disability status of persons with fibromyalgia. J Rheumatol 1997;24:1171-8.
20. Wolfe F. A comparison of IgM rheumatoid factor by nephelometry and latex methods: clinical and laboratory significance. Arthritis Care Res 1998;11:89-93.
21. Wolfe F, Michaud K. The clinical and research significance of the erythrocyte sedimentation rate. J Rheumatol 1994;21:1227-37.
22. Stata Corporation. Stata Statistical Software: Release 5.0. College Station, TX: Stata Corporation; 1997.
23. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
24. Cook RR, Delongchamp RR, Woodbury M, Perkins LL, Harrison MC. The prevalence of women with breast implants in the United States-1989. J Clin Epidemiol 1995;48:519-25.
25. Gabriel SE, O'Fallon WM, Beard CM, Kurland LT, Woods JE, Melton LJ. Trends in the utilization of silicone breast implants, 1964-1991, and methodology for a population-based study of outcomes. J Clin Epidemiol 1995;48:527-37.
26. Vasey FB. Observation on women with breast implants. J Fla Med Assoc 1995;82:348-51.
27. Report of the Independent Review Group. Silicone gel breast implants. www.silicone-review.gov.uk. 1-39, 1998.
28. Bar-Meir E, Teuber SS, Lin HC, et al. Multiple autoantibodies in patients with silicone breast implants. J Autoimmun 1995;8:267-77.
29. Rosenberg NL. The neuromythology of silicone breast implants. Neurology 1996;46:308-14.
30. Ferguson JH. Silicone breast implants and neurologic disorders. Report of the Practice Committee of the American Academy of Neurology. Neurology 1997;48:1504-7.
31. Dinerman H, Goldenberg DL, Felson DT. A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. J Rheumatol 1986;13:368-73.